Ligand Release-Independent Transactivation of Epidermal Growth Factor Receptor by Transforming Growth Factor-Β Involves Multiple Signaling Pathways

Oncogene - United Kingdom
doi 10.1038/sj.onc.1210649
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Targeting Transforming Growth Factor-Β Signaling

Current Opinion in Oncology
Cancer ResearchOncology
2007English

High- And Low-Affinity Epidermal Growth Factor Receptor-Ligand Interactions Activate Distinct Signaling Pathways

PLoS ONE
Multidisciplinary
2011English

Cooperative Induction of Transmembrane Prostate Androgen Induced Protein TMEPAI/PMEPA1 by Transforming Growth Factor-Β and Epidermal Growth Factor Signaling

Biochemical and Biophysical Research Communications
BiochemistryCell BiologyMolecular BiologyBiophysics
2015English

Activation of Rho Is Required for Ligand-Independent Oncogenic Signaling by a Mutant Epidermal Growth Factor Receptor

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2000English

Receptor Type Protein Tyrosine Phosphatase-Kappa Mediates Cross-Talk Between Transforming Growth Factor-Beta and Epidermal Growth Factor Receptor Signaling Pathways in Human Keratinocytes

Molecular Biology of the Cell
Cell BiologyMolecular Biology
2010English

Abrogation of Head and Neck Squamous Cell Carcinoma Growth by Epidermal Growth Factor Receptor Ligand Fused to Pseudomonas Exotoxin Transforming Growth Factor -PE38

Clinical Cancer Research
Cancer ResearchOncology
2004English

Transforming Growth Factor-Β

2005English

Transforming Growth Factor Β

2017English

Syndecan-2 Regulates Transforming Growth Factor-Β Signaling

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy